Abstract
Takotsubo cardiomyopathy (TTC) is characterized by reversible ventricular dysfunction induced by endogenous and, occasionally, exogenous catecholamine. We present a report on a patient who developed TTC and cardiogenic shock during percutaneous coronary intervention (PCI) secondary to inadvertent norepinephrine administration. His hemodynamic status and cardiac function were totally restored within 1 week after hemodynamic support using intra-aortic balloon pump without sequela. Thus, TTC should be considered once a patient presents with symptoms mimicking acute coronary syndrome (ACS) after catecholamine administration.
Keywords:
Cardiogenic shock; Catecholamine; Stress-induced cardiomyopathy.
MeSH terms
-
Adrenergic beta-1 Receptor Antagonists / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Bisoprolol / therapeutic use
-
Coronary Restenosis / surgery*
-
Creatine Kinase / blood
-
Creatine Kinase, MB Form / blood
-
Drug Overdose
-
Drug-Eluting Stents
-
Echocardiography
-
Humans
-
Hypotension / drug therapy*
-
Iatrogenic Disease
-
Intra-Aortic Balloon Pumping
-
Intraoperative Complications / drug therapy*
-
Male
-
Medication Errors*
-
Middle Aged
-
Norepinephrine / poisoning*
-
Percutaneous Coronary Intervention*
-
Recovery of Function
-
Shock, Cardiogenic / blood
-
Shock, Cardiogenic / chemically induced*
-
Shock, Cardiogenic / diagnosis
-
Shock, Cardiogenic / therapy
-
Stents
-
Stroke Volume
-
Takotsubo Cardiomyopathy / blood
-
Takotsubo Cardiomyopathy / chemically induced*
-
Takotsubo Cardiomyopathy / diagnostic imaging
-
Takotsubo Cardiomyopathy / therapy
-
Troponin I / blood
-
Valsartan / therapeutic use
-
Vasoconstrictor Agents / poisoning*
Substances
-
Adrenergic beta-1 Receptor Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Troponin I
-
Vasoconstrictor Agents
-
Valsartan
-
Creatine Kinase
-
Creatine Kinase, MB Form
-
Norepinephrine
-
Bisoprolol